Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab.

Name: Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab.
Author: Byrd, John C

Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab. — المؤلف: Byrd, John C — Blood 20191216

المؤلف: Byrd, John C
النشر: Blood 20191216
الوصف: 2031-2042 p.
الموضوعات: Adenine؛ Adult؛ Aged؛ Antibodies, Monoclonal, Humanized؛ Antineoplastic Agents, Immunological؛ Female؛ Follow-Up Studies؛ Humans